EcoDrugPlus

Retinoic Acid Receptor Gamma

Ensembl ID : ENSMLUG00000017284
Gene Symbol: RARG
2 Cross references
445 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSMLUG00000010476
Gene Symbol: RXRA
2 Cross references
244 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSMLUG00000014163
Gene Symbol: RXRB
2 Cross references
234 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSMLUG00000025626
Gene Symbol: RXRG
2 Cross references
274 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSMLUG00000000080
Gene Symbol: RPL10A
2 Cross references
167 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSMLUG00000008868
Gene Symbol: RPL11
4 Cross references
170 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSMLUG00000010950
Gene Symbol: RPL13
4 Cross references
268 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSMLUG00000014429
Gene Symbol: RPL14
2 Cross references
259 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSMLUG00000013809
Gene Symbol: RPL15
2 Cross references
110 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSMLUG00000009286
Gene Symbol: RPL18
2 Cross references
321 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSMLUG00000006701
Gene Symbol: RPL18A
2 Cross references
164 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSMLUG00000012555
Gene Symbol: RPL19
4 Cross references
312 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).